Ireland’s government remains confident in its ability to retain the country’s strategic position in pharmaceutical ...

Following hot on the heels of Monday’s European Commission EC approval of an indication extension for Johnson & Johnson’s ...

US biotech company Vertex Pharmaceuticals (Nasdaq: VRTX) has received European Commission approval to extend the use of its ...

Australia’s Therapeutics Goods Administration (TGA) has issued a safety notice on isotretinoin, originally sold as Roaccutane ...

The USA’s Centers for Medicare & Medicaid Services (CMS) yesterday released the Calendar Year (CY) 2026 Rate Announcement for ...

US biotech start-up RayThera has secured $110 million in series A financing to fund the early clinical development of its ...

The UK’s Prime Minister has announced action to accelerate the discovery of life-saving drugs, improve patient care and make ...

Alzheon, a privately-held clinical-stage biopharma company, presented promising Phase III APOLLOE4 trial results for ALZ-801 ...

South Korean clinical-stage biotech ABL Bio (Kosdaq: 298380) on Sunday announced a worldwide licensing agreement enabling GSK ...

Belgium’s influential biopharma industry is showing signs of strain for the first time in years, with both employment and ...

Italy-based Angelini Ventures, the corporate venture arm of Angelini Industries, has named Regina Hodits as managing director ...

French pharma major Sanofi and investment firm Cathay Capital have launched a $275 million fund that will invest in ...